原文: 换气次数：每小时空气更换不少于15次。

译文: 通风率：每小时空气更换不少于15次。
------------------------------------------------------------------------------------
原文: 附录项目

译文: 附录
------------------------------------------------------------------------------------
原文: 冷明红，M.S.                                                                     日期

译文: 冷明红，M.S. 日期
------------------------------------------------------------------------------------
原文: 性别和数量

译文: 性别与数量
------------------------------------------------------------------------------------
原文: (3) 门静脉/颈静脉的平均血药浓度比值sbk002剂量组为1.82，clo组为1.40，两者比较无明显差异。

译文: (3) 门静脉/颈静脉的平均血药浓度比sbk002剂量组为1.82，clo组为1.40，两者比较无明显差异。
------------------------------------------------------------------------------------
原文: 生产单位：苏州安威尔康实验动物用品有限公司；

译文: 制造商：苏州安威尔康实验动物用品有限公司；
------------------------------------------------------------------------------------
原文: 有效期至：2021-06-24（复检日期）；

译文: 有效期：2021-06-24（复检日期）；
------------------------------------------------------------------------------------
原文: 不适用

译文: 不适用
------------------------------------------------------------------------------------
原文: 有效期至：2022-03-14；

译文: 有效期：2022-03-14；
------------------------------------------------------------------------------------
原文: 性别比例：雌、雄各半；

译文: 性别比例：雌、雄各半；
------------------------------------------------------------------------------------
原文: 表1-2  SD大鼠灌胃给予sbk002及clo后血浆中sbk002平均血药浓度（ng/mL，n = 8）

译文: 表1-2 SD大鼠灌胃给予sbk002及clo后血浆中sbk002平均血药浓度（ng/mL，n = 8）
------------------------------------------------------------------------------------
原文: (2) SD大鼠灌胃给药clo后，在门静脉（推测肠道会代谢）会产生代谢产物H4，门静脉和颈静脉的质谱响应比较，无明显差异；

译文: (2) SD大鼠灌胃剂量clo后，在门静脉（推测肠道会代谢）会产生代谢产物H4，门静脉和颈静脉的质谱响应比较，无明显差异；
------------------------------------------------------------------------------------
原文: 平均滞留时间

译文: 平均滞留时间
------------------------------------------------------------------------------------
原文: 8.	数据采集和分析	17

译文: 8. 数据采集和分析 17
------------------------------------------------------------------------------------
原文: 批号：C1814029；

译文: 批号：C1814029；
------------------------------------------------------------------------------------
原文: 13.	附录项目	27

译文: 13. 附录 27
------------------------------------------------------------------------------------
原文: 水质常规指标的检测：具有江苏华测品标检测技术有限公司提供的检测报告（报告编号：A20190208613101）检测项目包括：pH值、色度、浑浊度、臭和味、肉眼可见物、总硬度、耗氧量、溶解性总固体、阴离子合成洗涤剂、挥发酚类、氰化物、六价铬、硫酸盐、氯化物、氟化物、硝酸盐氮、氯酸盐、亚氯酸盐、溴酸盐、总大肠菌群、耐热大肠菌群、大肠埃希氏菌、菌落总数、铝、铁、锰、铜、锌、砷、镉、铅、硒、汞、甲醛、氯仿（三氯甲烷）、四氯化碳、总α放射性、总β放射性，检测结果符合国标。

译文: 水质常规指标的检测：具有江苏华测品标检测技术有限公司提供的检测报告（报告编号：A20190208613101）检测项目包括：pH值、色度、浑浊度、臭和味、肉眼可见物、总硬度、耗氧量、溶解性总固体、阴离子合成洗涤剂、挥发酚类、氰化物、六价铬、硫酸盐、氯化物、氟化物、硝酸盐氮、氯酸盐、亚氯酸盐、溴酸盐、总大肠菌群、耐热大肠菌群、大肠埃希氏菌、菌落总数、铝、铁、锰、铜、锌、砷、镉、铅、硒、汞、甲醛、氯仿（三氯甲烷）、四氯化碳、总α放射性、总β放射性，检测结果符合国标。
------------------------------------------------------------------------------------
原文: 目的：SD大鼠灌胃分别给予sbk002和硫酸氢氯吡格雷（clo），测定sbk002血药浓度，定性确定活性代谢产物的有无[进行半定量研究（即活性代谢产物与sbk002的质谱信号比值）]，另计算大鼠sbk002及代谢产物门静脉/颈静脉的血药浓度比值。

译文: 目的：SD大鼠灌胃分别给予sbk002和硫酸氢氯吡格雷（clo），测定sbk002血药浓度，定性确定活性代谢产物的有无[进行半定量研究（即活性代谢产物与sbk002的质谱信号比率）]，另计算大鼠sbk002及代谢产物门静脉/颈静脉的血药浓度比率。
------------------------------------------------------------------------------------
原文: 测定动物：所有存活的试验动物。

译文: 待测动物：所有存活的试验动物。
------------------------------------------------------------------------------------
原文: 给药前对所有进入适应期的大鼠进行一般状态观察，检查不合格的动物不纳入试验。

译文: 给药前对已进入预试验阶段的所有大鼠进行一般状态观察，检查不合格的动物不纳入试验。
------------------------------------------------------------------------------------
原文: 专题负责人

译文: 研究负责人
------------------------------------------------------------------------------------
原文: 数据整理及统计分析：冷明红、叶双双、葛明玉。

译文: 数据整理及统计分析：冷明红、Shuangshuang Ye、葛明玉。
------------------------------------------------------------------------------------
原文: 图1-1 sbk002剂量组1M001门静脉血浆样品典型图

译文: 图1-1 sbk002剂量组1M001门静脉血浆样本典型图
------------------------------------------------------------------------------------
原文: 动物分组及剂量信息见下表：

译文: 动物组分配及剂量信息见下表：
------------------------------------------------------------------------------------
原文: 品系：SD大鼠；

译文: 品系：SD大鼠；
------------------------------------------------------------------------------------
原文: 3.	试验系统	11

译文: 3. 检测系统 11
------------------------------------------------------------------------------------
原文: 2.2.	操作/安全措施	11

译文: 2.2. 操作/安全措施 11
------------------------------------------------------------------------------------
原文: 传真：0512-36802288；

译文: 传真：0512-36802288；
------------------------------------------------------------------------------------
原文: sbk002剂量组门静脉血浆样品典型图谱见图1-1，颈静脉血浆样品典型图谱见图1-2；clo剂量组门静脉血浆样品典型图谱见图1-3，clo剂量组颈静脉血浆样品典型图谱见图1-4。

译文: sbk002剂量组门静脉血浆样本典型图谱见图1-1，颈静脉血浆样本典型图谱见图1-2；clo剂量组门静脉血浆样本典型图谱见图1-3，clo剂量组颈静脉血浆样本典型图谱见图1-4。
------------------------------------------------------------------------------------
原文: 垫料

译文: 垫料
------------------------------------------------------------------------------------
原文: 测定时间：给药前测定1次。

译文: 测量时间：给药前确定1次。
------------------------------------------------------------------------------------
原文: 推测H4和SM3为活性代谢产物和进一步代谢的甲基化产物。

译文: 推测H4和SM3为活性代谢产物和进一步代谢的甲基化产物。
------------------------------------------------------------------------------------
原文: 地址：成都高新区（西区）西芯大道17号；

译文: 地址：成都高新区（西区）西芯大道17号；
------------------------------------------------------------------------------------
原文: 垫料检测： 苏州安威尔康实验动物用品有限公司提供的垫料，具有谱尼测试提供垫料的检测报告（报告编号：BNAY0TLL8I072508），检测指标包括砷、铅、镉、汞、六六六、滴滴涕、黄曲霉毒素B1。检测结果符合要求。

译文: 垫料检测：苏州安威尔康实验动物用品有限公司提供的垫料，具有谱尼测试提供垫料的检测报告（报告编号：BNAY0TLL8I072508），检测指标包括砷、铅、镉、汞、六六六、滴滴涕、黄曲霉毒素B1。检测结果符合要求。
------------------------------------------------------------------------------------
原文: 垫料种类：玉米芯；

译文: 垫料类型：玉米芯；
------------------------------------------------------------------------------------
原文: 饲养环境条件标准：中华人民共和国国家标准GB14925-2010；

译文: 饲养环境条件标准：中华人民共和国国家标准GB14925-2010；
------------------------------------------------------------------------------------
原文: 联系人：武丽；

译文: 联系人：武丽；
------------------------------------------------------------------------------------
原文: 成都施贝康生物医药科技有限公号

译文: 成都施贝康生物医药科技有限公司；
------------------------------------------------------------------------------------
原文: 12.2.	归档内容	25

译文: 12.2. 存档数据 25
------------------------------------------------------------------------------------
原文: 成都施贝康生物医药科技有限公司

译文: 成都施贝康生物医药科技有限公司
------------------------------------------------------------------------------------
原文: 分钟

译文: 会议记录
------------------------------------------------------------------------------------
原文: 1.2.	试验目的	6

译文: 1.2. 研究目的 6
------------------------------------------------------------------------------------
原文: 雄

译文: 雄
------------------------------------------------------------------------------------
原文: 微克每毫升

译文: 微克每毫升
------------------------------------------------------------------------------------
原文: 接收和适应

译文: 动物接收和适应
------------------------------------------------------------------------------------
原文: 动物选择

译文: 动物选择
------------------------------------------------------------------------------------
原文: 3.4.	体重和年龄	12

译文: 3.4. 体重与年龄 12
------------------------------------------------------------------------------------
原文: 3.2.	性别和数量	11

译文: 3.2. 性别与数量 11
------------------------------------------------------------------------------------
原文: 动物管理和使用

译文: 动物管理和使用
------------------------------------------------------------------------------------
原文: 相对偏差

译文: 相对偏差
------------------------------------------------------------------------------------
原文: 12.3.	保存场所与保存条件	26

译文: 12.3. 存储场所与存储条件 26
------------------------------------------------------------------------------------
原文: 为实验动物提供玩具，作为环境改善措施。

译文: 为实验动物提供玩具，作为环境丰富措施。
------------------------------------------------------------------------------------
原文: 地址：

译文: 地址：
------------------------------------------------------------------------------------
原文: 垫料批号：AWR-20190408；

译文: 垫料批次号：AWR-20190408; 
------------------------------------------------------------------------------------
原文: 分组方法：分性别按体重随机分组。

译文: 组分配方法：按性别按体重随机分组。
------------------------------------------------------------------------------------
原文: （1）总结报告签字后2周内，专题负责人确保所有研究资料移交至档案室归档。

译文: (1)最终报告签署后2周内，研究负责人确保所有研究资料转移至档案室归档。
------------------------------------------------------------------------------------
原文: 小时

译文: 小时
------------------------------------------------------------------------------------
原文: 名称：成都施贝康生物医药科技有限公司；

译文: 名称：成都施贝康生物医药科技有限公司。 
------------------------------------------------------------------------------------
原文: 1.6.	遵循的法规及技术指导原则	7

译文: 1.6. 遵循的法规及技术指南 7
------------------------------------------------------------------------------------
原文: 7.2.	血药浓度检测	17

译文: 7.2. 血药浓度检测 17
------------------------------------------------------------------------------------
原文: 试验时间安排

译文: 试验时间安排
------------------------------------------------------------------------------------
原文: 设施内的所有原始数据根据试验方案和苏州华测生物技术有限公司的SOP手动收集或用数据采集系统收集。手动收集的数据转录到Excel表格中用来分析和报告。

译文: 设施内的所有原始数据根据研究方案和苏州华测生物技术有限公司的SOP手动收集或用数据采集系统收集。手动收集的数据转录到Excel表格中用于分析和报告。
------------------------------------------------------------------------------------
原文: 溶媒基本信息

译文: 载体一般信息
------------------------------------------------------------------------------------
原文: 专题名称及编号

译文: 研究名称及编号
------------------------------------------------------------------------------------
原文: 给药制剂在实验机构内的转移

译文: 剂量制剂在实验机构内的转移
------------------------------------------------------------------------------------
原文: 5.2.	试验方法	16

译文: 5.2. 试验方法 16
------------------------------------------------------------------------------------
原文: 半衰期

译文: 半衰期
------------------------------------------------------------------------------------
原文: sbk002剂量组

译文: sbk002剂量组
------------------------------------------------------------------------------------
原文: 给药容积：单次给药容积均为1 mL/kg。每只动物的给药量根据最近一次测量的体重进行调整；

译文: 剂量容积：单次剂量容积均为1 mL/kg。每只动物的剂量根据最近一次测量的体重进行调整；
------------------------------------------------------------------------------------
原文: 5.	试验设计	15

译文: 5. 研究设计 15
------------------------------------------------------------------------------------
原文: 剩余供试品处理：待本项目全部专题结束后退回委托方。

译文: 剩余试验物品处理：待本项目所有研究结束后退还给赞助商。
------------------------------------------------------------------------------------
原文: 代谢产物H4门静脉/颈静脉的平均质谱信号比值：SD大鼠灌胃给予sbk002后代谢产物H4门静脉平均质谱响应/颈静脉平均质谱响应比值为0.91；SD大鼠灌胃给予clo后代谢产物H4门静脉平均质谱响应/颈静脉平均质谱响应比值为1.16，两给药组比较无明显差异。

译文: 代谢产物H4门静脉/颈静脉的平均质谱信号比率：SD大鼠灌胃给予sbk002后代谢产物H4门静脉平均质谱响应/颈静脉平均质谱响应比率为0.91；SD大鼠灌胃给予clo后代谢产物H4门静脉平均质谱响应/颈静脉平均质谱响应比率为1.16，两剂量组比较无明显差异。
------------------------------------------------------------------------------------
原文: 采样方法和采样量：门静脉和颈静脉各采血约0.4 mL，收集的全血至含EDTA-K2的抗凝管中，轻柔混匀；

译文: 采样方法和采样量：门静脉和颈静脉各采集血液约0.4 mL，采集的全血至含EDTA-K2的抗凝管中，轻轻混匀；
------------------------------------------------------------------------------------
原文: SD大鼠灌胃给予sbk002及clo后，sbk002和clo个体门静脉和颈静脉血药浓度见表1-1，sbk002和clo的门静脉和颈静脉平均血药浓度见1-2。

译文: SD大鼠灌胃给予sbk002及clo后，sbk002和clo分别门静脉和颈静脉血药浓度见表1-1，sbk002和clo的门静脉和颈静脉平均血药浓度见表1-2。
------------------------------------------------------------------------------------
原文: SD大鼠灌胃给予sbk002后代谢产物SM3门静脉平均质谱响应/颈静脉平均质谱响应相对比值为0.85；SD大鼠灌胃给予clo后代谢产物SM3门静脉平均质谱响应/颈静脉平均质谱响应比值为1.12。

译文: SD大鼠灌胃给予sbk002后代谢产物SM3门静脉平均质谱响应/颈静脉平均质谱响应相对比率为0.85；SD大鼠灌胃给予clo后代谢产物SM3门静脉平均质谱响应/颈静脉平均质谱响应比率为1.12。
------------------------------------------------------------------------------------
原文: 大鼠灌胃sbk002及clo后的门静脉和颈静脉血药浓度比较

译文: 大鼠灌胃sbk002及clo后的门静脉和颈静脉血药浓度比较
------------------------------------------------------------------------------------
原文: SD大鼠灌胃给予sbk002及硫酸氢氯吡格雷肠道吸收试验

译文: SD大鼠灌胃给予sbk002及硫酸氢氯吡格雷肠道吸收试验
------------------------------------------------------------------------------------
原文: 操作/安全措施

译文: 操作/安全措施
------------------------------------------------------------------------------------
原文: 氯吡格雷的人体代谢产物及代谢途径：

译文: 氯吡格雷的人体代谢产物及代谢途径：
------------------------------------------------------------------------------------
原文: 配制方法：以配制1000 mL溶媒举例：准确称取5.0 g的CMC-Na粉末，用量筒量取1000 mL纯水转移至烧杯中，将CMC-Na粉末均匀分散在烧杯中，加入搅拌子，用磁力搅拌器搅拌至完全溶解，即得0.5 % CMC-Na溶液1000 mL。室温存放，8天内有效。

译文: 制备方法：以制备1000 mL载体为例：准确称取5.0 g的CMC-Na粉末，用量筒量取1000 mL纯水转移至烧杯中，将CMC-Na粉末均匀分散在烧杯中，加入搅拌子，用磁力搅拌器搅拌至完全溶解，即得0.5 % CMC-Na溶液1000 mL。室温存放，8天内有效。
------------------------------------------------------------------------------------
原文: 电话：0512-36801688；

译文: Telephone：0512-36801688；
------------------------------------------------------------------------------------
原文: 4.4.	饲养环境	13

译文: 4.4. Housing Environment 13
------------------------------------------------------------------------------------
原文: 观察时间：每天上午或下午观察1次；

译文: observation time: observe once every morning or afternoon;
------------------------------------------------------------------------------------
原文: 4.3.	动物饲养	13

译文: 4.3. Animal Housing 13
------------------------------------------------------------------------------------
原文: 本试验涉及的与动物试验相关的内容和程序都遵从实验动物使用和管理的相关法律法规和本机构实验动物使用和管理委员会（Institutional Animal Care and Use Committee，IACUC）的相关规定。动物数量、试验设计及动物的处理都已通过本机构IACUC审批(审批号：IACUC-B2019023-K09-01)，并严格按IACUC批准的内容执行。

译文: All content and procedures related to animal experiments involved in this assay comply with the relevant laws, regulations on the use and management of laboratory animals, and the relevant provisions of the Institutional Animal Care and Use Committee (IACUC) of this institution. The number of animals, study design, and disposal of animals have been approved by the IACUC of this institution (approval batch number: IACUC-B2019023-K09-01), and are strictly carried out according to the content approved by the IACUC.
------------------------------------------------------------------------------------
原文: 禁食给食：给药前禁食12 h以上，试验期间不禁水；

译文: fasted feeding: fast for more than 12 hours pre-dose, no water restriction during the assay;
------------------------------------------------------------------------------------
原文: (2) SD大鼠灌胃给药clo后，在门静脉（推测肠道会代谢）会产生代谢产物SM3，门静脉和颈静脉的质谱响应比较，无明显差异；

译文: (2) After SDrats were gavaged with dose clo, metabolism product SM3 was generated in the portal vein (suspected intestinal metabolism). Comparing the mass spectrometry response between the portal vein and the jugular vein, there is no significant difference;
------------------------------------------------------------------------------------
原文: 3.1.	品种/品系/级别	11

译文: 3.1. Variety/strain/level 11
------------------------------------------------------------------------------------
原文: 专题名称：SD大鼠灌胃给予sbk002及clo肠道吸收

译文: Study Name: SDrats gavage administration of sbk002 and clo for intestinal absorption
------------------------------------------------------------------------------------
原文: 由于氯吡格雷是前药，在人体内经过肝CYP450酶两步代谢生成活性代谢产物，氯吡格雷首先被氧化成2-氧-氯吡格雷，2-氧-氯吡格雷有2个异构体，其中一个异构体为sbk002；2-氧-氯吡格雷进一步代谢形成唯一的硫醇活性代谢产物H4和非活性代谢产物H3,活性成分H4和H3可进一步甲基化为SM3。

译文: Since clopidogrel is a prodrug, in human in vivo, it undergoes two-step metabolism in the liver by CYP450 enzymes to produce the active metabolism product. Clopidogrel is first oxidized to 2-oxo-clopidogrel, which has two isomers, one of which is sbk002. 2-oxo-clopidogrel is further metabolized to form the only active thiol metabolism product H4 and inactive metabolism product H3. The active ingredients H4 and H3 can be further methylated to form SM3.
------------------------------------------------------------------------------------
原文: 收集和报告电子数据的采集系统如下：

译文: The system for collecting and reporting electron data is as follows: 
------------------------------------------------------------------------------------
原文: 4.7.	垫料	14

译文: 4.7. bedding 14
------------------------------------------------------------------------------------
原文: 供试品2基本信息

译文: test article 2 General Information 
------------------------------------------------------------------------------------
原文: 本试验拟探索sbk002和clo在大鼠体内代谢的主要部位。给药后3小时，立即CO2麻醉，进行手术，裸露门静脉和颈静脉，于门静脉和颈静脉各采血 0.4 mL。测定sbk002血药浓度，定性确定活性代谢产物的有无[进行半定量研究（即活性代谢产物与sbk002的质谱信号比值）]，另计算大鼠sbk002及代谢产物门静脉/颈静脉的血药浓度比值。

译文: This assay aims to explore the main metabolism site of sbk002 and clo in rats in vivo. After dosing for 3 hours, immediately perform CO2 anesthesia, perform surgery, expose the portal vein and jugular vein, and collect 0.4 mL of blood from each of the portal vein and jugular vein. Determine the blood concentration of sbk002, qualitatively determine the presence of active metabolism products [perform semi-quantitative study (i.e., the mass spectrometry signal ratio of active metabolism products to sbk002)], and additionally calculate the blood concentration ratio of sbk002 and metabolism products in the portal vein/jugular vein of rats.
------------------------------------------------------------------------------------
原文: 年龄：购入时8 ~ 11周龄，分组时9 ~ 12周龄。

译文: age: 8 ~ 11 weeks old at purchase, 9 ~ 12 weeks old at Group Assignment.
------------------------------------------------------------------------------------
原文: 版本

译文: version
------------------------------------------------------------------------------------
原文: 3.6.	实验动物选择依据和数量	12

译文: 3.6. justification for laboratory animals selection and number 12
------------------------------------------------------------------------------------
原文: 12.	资料保存	25

译文: 12. Storage of Relevant Data 25
------------------------------------------------------------------------------------
原文: 表1-1  SD大鼠灌胃给予sbk002及clo后血浆中sbk002个体血药浓度（ng/mL）

译文: Table 1-1: Plasma sbk002 individual blood concentration (ng/mL) after SDrats were gavaged with sbk002 and clo
------------------------------------------------------------------------------------
原文: 饲养环境

译文: Housing Environment
------------------------------------------------------------------------------------
原文: 保存与使用：低温、干燥、卫生；将灭菌的垫料铺于大鼠笼盒底部，以铺满整个底部为宜；

译文: Storage and use: low temperature, dry, hygienic; spread sterilized bedding at the bottom of the rats' cage, covering the entire bottom as appropriate;
------------------------------------------------------------------------------------
原文: 联系电话：0512-36801688。

译文: Contact Telephone: 0512-36801688.
------------------------------------------------------------------------------------
原文: 摘   要	5

译文: Abstract 5
------------------------------------------------------------------------------------
原文: 8.1.	收集和报告电子数据的采集系统如下：	17

译文: 8.1. The system for collecting and reporting electron data is as follows: 17
------------------------------------------------------------------------------------
原文: 配制方法

译文: preparation method
------------------------------------------------------------------------------------
原文: 7.1.	血样采集	16

译文: 7.1. blood sample collection 16
------------------------------------------------------------------------------------
原文: 签   字   页	2

译文: Signature Page 2
------------------------------------------------------------------------------------
原文: 代谢产物SM3门静脉/颈静脉的平均质谱信号比值：SD大鼠灌胃给予sbk002后代谢产物SM3门静脉平均质谱响应/颈静脉平均质谱响应比值为0.85；SD大鼠灌胃给予clo后代谢产物SM3门静脉平均质谱响应与颈静脉平均质谱响应比值为1.12，两给药组比较无明显差异。

译文: Mean mass spectrometry signal ratio of metabolism product SM3 in the portal vein/jugular vein: After SDrats were gavaged with sbk002, the mean mass spectrometry response ratio of the metabolism product SM3 in the portal vein/jugular vein was 0.85. After SDrats were gavaged with clo, the mean mass spectrometry response ratio of the metabolism product SM3 in the portal vein/jugular vein was 1.12. There is no significant difference between the two dose groups.
------------------------------------------------------------------------------------
原文: H4分子量为355，[M+H]+=356，SM3的分子量为369，[M+H]+=370；通过质谱检测血浆样品中荷质比为356、370化合物，根据相对于sbk002的保留时间和荷质比初步推测是否可能产生活性代谢产物H4和进一步代谢产物SM3，并获得其质谱响应值。

译文: H4 Molecular weight: 355, [M+H]+=356; SM3 Molecular weight: 369, [M+H]+=370. Through mass spectrometry testing of plasma samples, compounds with mass-to-charge ratios of 356 and 370 are preliminarily suspected of being the active metabolism product H4 and the further metabolized product SM3 based on their retention time relative to sbk002 and their mass-to-charge ratio. Their mass spectrometry response values were obtained.
------------------------------------------------------------------------------------
原文: 品种/品系/级别

译文: variety/strain/level
------------------------------------------------------------------------------------
原文: 液质联用仪

译文: Liquid chromatography-mass spectrometry
------------------------------------------------------------------------------------
原文: 相对湿度：40 % ~ 70 %；

译文: Relative humidity: 40% ~ 70%;
------------------------------------------------------------------------------------
原文: 剂量
(mg / kg)

译文: dose (mg/kg)
------------------------------------------------------------------------------------
原文: 结论

译文: Conclusion
------------------------------------------------------------------------------------
原文: 附件一：试验方案

译文: Appendix One: study protocol
------------------------------------------------------------------------------------
原文: 饲养密度：≤4只/笼。

译文: Housing density: ≤4 per cage.
------------------------------------------------------------------------------------
原文: 3.5.	动物标识	12

译文: 3.5. Animal Identification 12
------------------------------------------------------------------------------------
原文: 给药途径：灌胃；

译文: route of administration: gavage;
------------------------------------------------------------------------------------
原文: 本机构实验动物使用许可证号：SYXK(苏）2018-0051；

译文: The laboratory animal use license number of this institution: SYXK(Su) 2018-0051;
------------------------------------------------------------------------------------
原文: 一般状态观察

译文: general states observation
------------------------------------------------------------------------------------
原文: 地址：江苏省昆山市高新区元丰路166号；

译文: Address: No. 166 Yuanfeng Road, New & Hi-tech Industrial Development Zone, Kunshan City, Jiangsu Province;
------------------------------------------------------------------------------------
原文: 平均质谱响应比值

译文: mean mass spectrometry response ratio
------------------------------------------------------------------------------------
原文: 本试验不是以前任何试验的简单重复，没有其他替代试验可以解决；并且经文献检索，没有其他可以引起较少疼痛和紧张的方法可以替代本试验中提到的操作方法。

译文: This assay is not a simple repetition of any previous assay. There is no other alternative assay that can solve the issues addressed by this assay. And according to the literature review, there is no other method that can be used to cause less pain and tension than the methods mentioned in this assay to replace it.
------------------------------------------------------------------------------------
原文: 7.3.	结果分析	17

译文: 7.3. result analyzed 17
------------------------------------------------------------------------------------
原文: 所有剂量组采样时间：给药后3 h（± 15 min）。

译文: Sampling time for all dose groups: 3 hours (± 15 min) after dosing.
------------------------------------------------------------------------------------
原文: 缩略词表

译文: ABBREVIATION INDEX
------------------------------------------------------------------------------------
原文: 2.3.	给药制剂在实验机构内的转移	11

译文: 2.3. metastasis of dose formulations in the experimental institution 11
------------------------------------------------------------------------------------
原文: 供试品1基本信息

译文: test article 1 General Information
------------------------------------------------------------------------------------
原文: 兽医：王海洋、徐堃；

译文: Veterinarian: Wang Haiyang, Xu Kun;
------------------------------------------------------------------------------------
原文: 颈静脉

译文: jugular vein 
------------------------------------------------------------------------------------
原文: (1) SD大鼠灌胃给药sbk002后，在门静脉（推测肠道会代谢）会产生代谢产物H4，门静脉和颈静脉的质谱响应比较，无明显差异；

译文: (1) After SDrats were gavaged with dose sbk002, metabolism product H4 was generated in the portal vein (suspected intestinal metabolism). Comparing the mass spectrometry response between the portal vein and the jugular vein, there is no significant difference;
------------------------------------------------------------------------------------
原文: (4) sbk002组（10 mg/kg）灌胃3小时后门静脉和颈静脉中的代谢产物SM3的平均质谱响应均显著高于clo组（30 mg/kg），说明clo在肠道或肝脏转化为代谢产物SM3的转化率低，与文献报道一致，

译文: (4) After 3 hours of gavage with the sbk002 group (10 mg/kg), the mean mass spectrometry response of the metabolism product SM3 in the portal vein and jugular vein is significantly higher than that in the clo group (30 mg/kg), indicating a lower conversion rate of clo to the metabolism product SM3 in the intestine or liver, consistent with literature reports.
------------------------------------------------------------------------------------
原文: 动物数量选择理由：在满足研究目的、科学标准和法规要求的前提下，使用尽可能少的动物。试验共分2组，每组8只，雌、雄各半，共使用16只SD大鼠，可满足获取足够实验数据的最低动物数目要求，为防止所购实验动物由于未知原因导致不能满足试验需求的情形发生，额外多申购2只动物/性别。

译文: Justification for selection of the number of laboratory animals: Under the premise of meeting the research objectives, scientific standards, and regulations, as few animals as possible were used. The assay is divided into 2 groups, each with 8 rats, half male and half female, using a total of 16 SDrats, which is the minimum number of animals required to obtain enough experimental data. To prevent situations where the purchased laboratory animals do not meet the assay requirements due to unknown reasons, 2 extra animals/sex were additionally purchased.
------------------------------------------------------------------------------------
原文: 试验原始资料（包括电子资料）

译文: assay raw data (including electronic data)
------------------------------------------------------------------------------------
原文: 性状：白色至灰色粉末或晶体；

译文: Characterization: white to gray powder or crystals;
------------------------------------------------------------------------------------
原文: 专题编号：B2019023-K09-01

译文: study number: B2019023-K09-01
------------------------------------------------------------------------------------
原文: 门静脉/颈静脉

译文: portal vein/jugular vein 
------------------------------------------------------------------------------------
原文: 推测本次试验中考察的化合物356和370即为活性代谢产物H4和进一步代谢的甲基化产物SM3。

译文: It is suspected that the compounds 356 and 370 studied in this assay are the active metabolism product H4 and the further metabolized methylated product SM3.
------------------------------------------------------------------------------------
原文: 注：动物编号的首位数字代表组别（1和2分别代表sbk002剂量组和clo剂量组），第二位字母F表示雌性，M表示雄性。后3位数字代表动物序列号。

译文: Note: The first digit of the animal number represents the group (1 and 2 represent the sbk002 dose group and the clo dose group respectively). The second letter F represents female, and M represents male. The last 3 digits represent the animal's sequence number.
------------------------------------------------------------------------------------
原文: 微生物指标：具有谱尼测试提供的检测报告（报告编号：GNALX2IA1S1068946）检测指标包括菌落总数、大肠菌群、霉菌和酵母菌计数、沙门氏菌。检测结果符合国标。

译文: Microbial indicators: with a testing report provided by Poni Testing (report number: GNALX2IA1S1068946), the testing indicators include total bacterial count, large intestine flora, mold and yeast count, and Salmonella. The testing results meet the national standard.
------------------------------------------------------------------------------------
原文: 10.	结论	25

译文: 10. Conclusion 25
------------------------------------------------------------------------------------
原文: 动物饲养管理：李永超；

译文: Animal Housing management: Li Yongchao;
------------------------------------------------------------------------------------
原文: 专题编号B2019023-K09-01-Rv1

译文: study number B2019023-K09-01-Rv1
------------------------------------------------------------------------------------
原文: 在室温、避光条件下，准确称取303.6 mg的clo至研钵中，加入适量0.5 % CMC-Na溶液充分研磨后，完全转移至标定体积的容器中，用0.5 % CMC-Na加至标定刻度，搅拌均匀后即得浓度为30 mg/mL 的clo剂量组给药制剂10 mL。

译文: At room temperature, protected from excessive light conditions, accurately weigh 303.6 mg of clo into a mortar, add an appropriate amount of 0.5% CMC-Na solution, grind fully, transfer completely to a calibrated volumetric container, add 0.5% CMC-Na to the calibrated mark, stir well to obtain a concentration of 30 mg/mL clo dose group dose formulations of 10 mL.
------------------------------------------------------------------------------------
原文: 6.2.	体重	16

译文: 6.2. body weight 16
------------------------------------------------------------------------------------
原文: 来源

译文: source
------------------------------------------------------------------------------------
原文: 主要仪器设备

译文: Major Instruments equipment
------------------------------------------------------------------------------------
原文: 个体编号

译文: individual number
------------------------------------------------------------------------------------
原文: 邮编：215300；

译文: Postal Code: 215300;
------------------------------------------------------------------------------------
原文: 根据研究机构的SOPs制定笼卡，每只动物通过尾部标记和笼卡作为动物识别标记。

译文: According to the SOPs of the test facility, cage cards are formulated. Each animal is labeled through tail labeling and cage card as animal identification labeling.
------------------------------------------------------------------------------------
原文: 提供单位：浙江维通利华实验动物技术有限公司；

译文: Supplier：Zhejiang Weitong Lihua Laboratory Animals Technique Co., Ltd.;
------------------------------------------------------------------------------------
原文: 签   字   页

译文: Signature Page
------------------------------------------------------------------------------------
原文: 4.	动物的饲养和管理	12

译文: 4. Housing and management of animals 12
------------------------------------------------------------------------------------
原文: (1) SD大鼠灌胃给药sbk002后，在门静脉（推测肠道会代谢）产生代谢产物SM3，门静脉和颈静脉的质谱响应比较，无明显差异；

译文: (1) After SD rats were orally administered with sbk002, metabolism product SM3 was generated in the portal vein (speculated to be metabolized in the intestines). Comparing the mass spectrometry response of the portal vein and the cervical vein, there was no significant difference;
------------------------------------------------------------------------------------
原文: 6.1.	一般状态观察	16

译文: 6.1. General states observation 16
------------------------------------------------------------------------------------
原文: 保存场所与保存条件

译文: Storage places and storage conditions
------------------------------------------------------------------------------------
原文: 标准偏差

译文: Standards deviation
------------------------------------------------------------------------------------
原文: 生产厂家：阿拉丁 (Aladdin ）；

译文: Manufacturer: Aladdin;
------------------------------------------------------------------------------------
原文: clo给药制剂配制方法：根据SD大鼠最近一次体重、给药剂量计算所需供试品的量，根据供试品的量、配制浓度计算配制体积（配制体积=阳性对照品量×含量/配制浓度）。在室温、避光条件下，准确称取一定量的供试品研钵中，加入适量的溶媒充分研磨后，完全转移至一定体积的容器内，用溶媒定至刻度，即得所需浓度的供试品剂量组给药制剂。

译文: clodose formulations preparation method: according to the most recent body weight of SD rats and the dosage calculation of the test article required, calculate the prepared volume based on the amount of test article and the preparation concentration (prepared volume = amount of positive reference item × content/preparation concentration). Accurately weigh a certain amount of test article into a mortar under room temperature and protect from excessive light conditions, add an appropriate amount of vehicle and grind fully, then completely transfer to a container of a certain volume, and use the vehicle to make up to the scale to obtain the desired concentration of the test article dose group dose formulations.
------------------------------------------------------------------------------------
原文: 规格：2.2 g/袋；

译文: size: 2.2 g/bag;
------------------------------------------------------------------------------------
原文: 联系人：牟霞；

译文: Contact person: Mu Xia;
------------------------------------------------------------------------------------
原文: 归档时间及档案保存时间

译文: Archiving Time and archives storage time
------------------------------------------------------------------------------------
原文: 9.1.	大鼠灌胃sbk002及clo后的门静脉和颈静脉血药浓度比较	19

译文: 9.1. Comparison of blood concentration between the portal vein and cervical vein after oral administration of sbk002 and clo in rats 19
------------------------------------------------------------------------------------
原文: 其中“Plasma-1”为首份检测样品，分装血浆体积为100 μL，剩余血浆样品作为备份保存于“Plasma-2”管中。置于≤ -60 ℃以下保存。分析结束后剩余血浆样本于试验结束后6个月根据委托方的授权意见销毁或移交委托方。

译文: Among them, “Plasma-1” was the first testing sample, sub-packaged plasma volume was 100 μL, and the remaining plasma sample was stored as backup in the "Plasma-2" tube. Store at ≤ -60 ℃. After the analysis is completed, the remaining plasma samples will be destroyed or transferred to the sponsor according to the authorization of the sponsor 6 months after the end of the assay.
------------------------------------------------------------------------------------
原文: 实验动物接收后先适应环境7天。

译文: Laboratory animals were first acclimated for 7 days after reception.
------------------------------------------------------------------------------------
原文: 研究机构按照《职业卫生安全与防护手册》来操作。在试验操作时，穿戴合适的个人防护设备（PPE）及护目镜。

译文: The test facility operates according to the "Occupational Health Safety and Protection Manual." During the assay operations, wear appropriate personal protective equipment (PPE) and goggles.
------------------------------------------------------------------------------------
原文: Confidential                                                                             第 5页 /共 29页

译文: Confidential page 5 of 29
------------------------------------------------------------------------------------
原文: 名称：苏州华测生物技术有限公司；

译文: Name: Suzhou Huace Bio-Tech Co., Ltd.;
------------------------------------------------------------------------------------
原文: 表观分布容积

译文: Apparent distribution volume
------------------------------------------------------------------------------------
原文: 组别

译文: Group
------------------------------------------------------------------------------------
原文: 归档内容

译文: Archived Data
------------------------------------------------------------------------------------
原文: 观察动物：所有存活试验动物。

译文: Animals to be observed: all surviving assay animals.
------------------------------------------------------------------------------------
原文: 性状：类白色结晶性粉末；

译文: Characterization: off-white crystalline powder;
------------------------------------------------------------------------------------
原文: 剩余给药制剂处理：返还供试品管理部，按药物/化学废弃物进行处理；

译文: Remaining dose formulations disposal: return to the test article management department, dispose of according to medication/chemical waste regulations;
------------------------------------------------------------------------------------
原文: 体重

译文: body weight
------------------------------------------------------------------------------------
原文: 试验设计

译文: study design
------------------------------------------------------------------------------------
原文: 组别设计：sbk002剂量组、clo剂量组；

译文: Group design: sbk002 dose group, clo dose group;
------------------------------------------------------------------------------------
原文: 4.8.	饮水	14

译文: 4.8. Drinking Water 14
------------------------------------------------------------------------------------
原文: 试验方案、偏离和变更

译文: study protocol, deviation, and amendments
------------------------------------------------------------------------------------
原文: 毫升

译文: Milliliter
------------------------------------------------------------------------------------
原文: 试验

译文: assay
------------------------------------------------------------------------------------
原文: 总结报告

译文: final report
------------------------------------------------------------------------------------
原文: 姓名：冷明红；

译文: Name: Leng Minghong;
------------------------------------------------------------------------------------
原文: (2) clo灌胃后，能够在门静脉（推测肠道会代谢）产生sbk002，门静脉血药浓度和颈静脉血药浓度比较，无明显差异。

译文: (2) After oral administration of clo, sbk002 could be generated in the portal vein (speculated to be metabolized in the intestines). Comparing the blood concentration in the portal vein and cervical vein, there was no significant difference.
------------------------------------------------------------------------------------
原文: 表1-4  SD大鼠灌胃给予sbk002及clo血浆中H4与sbk002平均质谱信号比值

译文: Table 1-4 comparison of the mean mass spectrometry signal ratio of H4 and sbk002 in the plasma of SD rats orally administered with sbk002 and clo
------------------------------------------------------------------------------------
原文: 标识方法：所配制的sbk002剂量组和clo剂量组分别用绿色和红色标签标识，并注明专题编号、名称、浓度、数量、配制日期、配制者、贮存条件、有效期至、成品编号。

译文: Identification method: use green and red labels respectively for the prepared sbk002 dose group and clo dose group, and specify the study number, name, concentration, number, preparation date, preparer, storage conditions, expiry date, and finished product number.
------------------------------------------------------------------------------------
原文: 毫克

译文: Milligram
------------------------------------------------------------------------------------
原文: 缩略词表	3

译文: ABBREVIATION INDEX 3
------------------------------------------------------------------------------------
原文: 进入适应期动物数量和性别：20只，雌、雄各半；

译文: Entered pretest phase animal number and sex: 20 rats, half male and half female;
------------------------------------------------------------------------------------
原文: 9.	结果	19

译文: 9. result 19
------------------------------------------------------------------------------------
原文: 规格：500 g；

译文: size: 500 g;
------------------------------------------------------------------------------------
原文: 样品分析：吴津津、吴宗斌；

译文: sample analyzed: Wu Jinjin, Wu Zongbin;
------------------------------------------------------------------------------------
原文: SD大鼠灌胃给予sbk002及clo后：血浆中sbk002和H4质谱响应见1-3，H4与sbk002平均质谱响应比值见1-4；sbk002和SM3质谱响应见1-5，SM3与sbk002平均质谱响应比值见1-6。

译文: After oral administration of sbk002 and clo to SD rats: the mass spectrometry responses of sbk002 and H4 in plasma are shown in 1-3, the mean mass spectrometry response ratio of H4 and sbk002 is shown in 1-4; the mass spectrometry response of sbk002 and SM3 is shown in 1-5, the mean mass spectrometry response ratio of SM3 and sbk002 is shown in 1-6.
------------------------------------------------------------------------------------
原文: 毫升每分钟

译文: Milliliter per Minute
------------------------------------------------------------------------------------
原文: 有效期至：2021-06-10（暂定）；

译文: Expiry date: 2021-06-10 (tentative);
------------------------------------------------------------------------------------
原文: 清除率

译文: Clearance rate
------------------------------------------------------------------------------------
原文: clo剂量组

译文: clodose group
------------------------------------------------------------------------------------
原文: 邮编：611731；

译文: Postal code: 611731;
------------------------------------------------------------------------------------
原文: LC-MS/MS检测浓度

译文: LC-MS/MS testing concentration
------------------------------------------------------------------------------------
原文: 英文缩写

译文: Abbreviation
------------------------------------------------------------------------------------
原文: 1.3.	研究机构	6

译文: 1.3. test facility 6
------------------------------------------------------------------------------------
原文: 试验系统

译文: test system
------------------------------------------------------------------------------------
原文: 研究机构

译文: test facility
------------------------------------------------------------------------------------
原文: 动物的饲养和管理

译文: Housing and management of animals
------------------------------------------------------------------------------------
原文: 7.	血样采集及检测分析	16

译文: 7. Blood sample collection and testing analyzed 16
------------------------------------------------------------------------------------
原文: 饲养环境控制系统：MSEA-MVE 6.0江森动物房环境监测系统；

译文: Housing Environment Control System: MSEA-MVE 6.0 Johnson Animal House Environment Monitoring System;
------------------------------------------------------------------------------------
原文: 4.1.	动物管理和使用	12

译文: 4.1. animal management and use 12
------------------------------------------------------------------------------------
原文: 电话：

译文: Telephone: 
------------------------------------------------------------------------------------
原文: 剂量

译文: dose
------------------------------------------------------------------------------------
原文: 变异系数

译文: Coefficient of variation
------------------------------------------------------------------------------------
原文: (4) sbk002组（10 mg/kg）灌胃3小时后，门静脉和颈静脉中sbk002的平均血药浓度均显著高于clo组（30 mg/kg），说明clo在肠道或肝脏转化为sbk002的转化率较低，和文献报道一致.由于sbk002本身就通过肠道吸收，故sbk002组门静脉中的sbk002血药浓度偏高也属正常。

译文: (4) Three hours after oral administration of sbk002 (10 mg/kg), the mean blood concentration of sbk002 in the portal vein and cervical vein was significantly higher than that of the clo group (30 mg/kg), indicating that the conversion rate of clo to sbk002 in the intestines or liver is relatively low, consistent with literature reports. Since sbk002 itself is absorbed through the intestines, it is normal for the blood concentration of sbk002 in the portal vein of the sbk002 group to be higher.
------------------------------------------------------------------------------------
原文: 给药剂量：sbk002剂量组给药剂量为10 mg/kg。clo剂量组给药剂量为30 mg/kg；

译文: Dosage: sbk002 dose group dosage is 10 mg/kg. Clo dose group dosage is 30 mg/kg;
------------------------------------------------------------------------------------
原文: 液质连用仪

译文: Liquid chromatography-mass spectrometry instrument
------------------------------------------------------------------------------------
原文: 观察内容：包括但不限于一般表现、行为状态、眼睛、口腔、鼻口部、耳、毛发及皮肤、粪便、尿、生殖器等毒性症状；

译文: Observation items: including but not limited to general conditions, behavioral status, eyes, oral cavity, muzzle, ears, hair and skin, feces, urine, genitalia, and other toxicity symptoms;
------------------------------------------------------------------------------------
原文: 制造商

译文: Manufacturer
------------------------------------------------------------------------------------
原文: 药代动力学试验采血时间和动物编号见下表：

译文: Pharmacokinetics assay Blood Sampling Time and animal number are shown in the table below:
------------------------------------------------------------------------------------
原文: 动物饲养

译文: Animal Housing
------------------------------------------------------------------------------------
原文: 给药浓度：sbk002剂量组给药浓度为10 mg/kg。clo剂量组给药浓度为30 mg/kg；

译文: Dose Concentration: sbk002 dose group dose concentration is 10 mg/kg. Clo dose group dose concentration is 30 mg/kg;
------------------------------------------------------------------------------------
原文: 保存条件：常规；

译文: Storage condition: routine;
------------------------------------------------------------------------------------
原文: 保存条件：室温；

译文: Storage condition: room temperature;
------------------------------------------------------------------------------------
原文: 给药后3 h

译文: after dosing 3 h
------------------------------------------------------------------------------------
原文: 毫克每毫升

译文: Milligram per Milliliter
------------------------------------------------------------------------------------
原文: 门静脉SM3/颈静脉SM3

译文: portal vein SM3/cervical vein SM3
------------------------------------------------------------------------------------
原文: 峰浓度

译文: Peak concentration
------------------------------------------------------------------------------------
原文: 动物编号

译文: animal number
------------------------------------------------------------------------------------
原文: 在室温、避光条件下，准确称取100.6 mg的sbk002至研钵中，加入适量0.5 % CMC-Na溶液充分研磨后，完全转移至标定体积的容器中，用0.5 % CMC-Na加至标定刻度，搅拌均匀后即得浓度为10 mg/mL 的sbk002剂量组给药制剂10 mL。

译文: Accurately weigh 100.6 mg of sbk002 into a mortar, add an appropriate amount of 0.5% CMC-Na solution and grind fully under room temperature and protected from excessive light conditions, then completely transfer to a container of calibrated volume, use 0.5% CMC-Na to make up to the calibrated scale, stir evenly to obtain the concentration of 10 mg/mL sbk002 dose group dose formulations 10 mL.
------------------------------------------------------------------------------------
原文: 实验动物选择依据和数量

译文: Laboratory animals' selection justification and number
------------------------------------------------------------------------------------
原文: 低于定量下限

译文: lower than the lower limit of quantification
------------------------------------------------------------------------------------
原文: 系统

译文: system
------------------------------------------------------------------------------------
原文: 4.5.	环境改善	13

译文: 4.5. Environmental Enrichment 13
------------------------------------------------------------------------------------
原文: 委托单位

译文: Sponsor
------------------------------------------------------------------------------------
原文: SD大鼠灌胃给予sbk002后代谢产物H4门静脉平均质谱响应/颈静脉平均质谱响应相对比值为0.91；SD大鼠灌胃给予clo后代谢产物H4门静脉平均质谱响应/颈静脉平均质谱响应比值为1.16。

译文: After oral administration of sbk002 to SD rats, the relative ratio of the mean mass spectrometry response of H4 in the portal vein to the mean mass spectrometry response in the cervical vein was 0.91; after oral administration of clo to SD rats, the ratio was 1.16.
------------------------------------------------------------------------------------
原文: 电子邮件：lengminghong@cti-cert.com。

译文: email: lengminghong@cti-cert.com.
------------------------------------------------------------------------------------
原文: 血药浓度检测

译文: Blood concentration testing
------------------------------------------------------------------------------------
原文: 附件一：试验方案	28

译文: Appendix one: study protocol 28
------------------------------------------------------------------------------------
原文: 4.2.	接收和适应	13

译文: 4.2. Animal Receipt and Acclimation 13
------------------------------------------------------------------------------------
原文: 目 录

译文: Table of Contents
------------------------------------------------------------------------------------
原文: 试验方法

译文: assay method
------------------------------------------------------------------------------------
原文: 浓度

译文: concentration
------------------------------------------------------------------------------------
原文: 保存场所：苏州华测生物技术有限公司档案管理部；

译文: Storage place: Suzhou Huace Bio-Tech Co., Ltd. Archives Management Department;
------------------------------------------------------------------------------------
原文: 1.5.	试验人员组成	7

译文: 1.5. Study Personnel composition 7
------------------------------------------------------------------------------------
原文: 12.1.	归档时间及档案保存时间	25

译文: 12.1. Archiving Time and archives storage time 25
------------------------------------------------------------------------------------
原文: 温度：20 ~ 26 ℃（日温差 ≤ 4 ℃）；

译文: temperature: 20 ~ 26 ℃ (daily temperature difference ≤ 4 ℃);
------------------------------------------------------------------------------------
原文: (1) sbk002经灌胃后，通过肠道吸收，门静脉血药浓度和颈静脉血药浓度比较，无明显差异。

译文: (1) After gavage with sbk002, it is absorbed through the intestines, and there is no significant difference in the blood concentration between the portal vein and the cervical vein.
------------------------------------------------------------------------------------
原文: 适应期第1天定义为P1，首次给药当天定义为给药期第1天（day 1，D1）。

译文: The first day of the pretest phase is defined as P1, and the first day of dosing is defined as the first day of the dosing phase (day 1, D1). 
------------------------------------------------------------------------------------
原文: 试验主要组成人员

译文: assay mainly composed personnel 
------------------------------------------------------------------------------------
原文: 化学污染物：具有谱尼测试提供的检测报告（报告编号：GNALX2IA1S1068945），检测指标包括砷、铅、镉、汞、六六六、滴滴涕、黄曲霉毒素B1。检测结果符合国标。

译文: Chemical pollutants: with a testing report provided by Pony Testing (report number: GNALX2IA1S1068945), the testing indicators include arsenic, lead, cadmium, mercury, BHC, DDT, and aflatoxin B1. The testing results meet national standards.
------------------------------------------------------------------------------------
原文: 观察

译文: observation
------------------------------------------------------------------------------------
原文: 配制方法：准确称取一定量的CMC-Na粉末，用量筒量取一定体积的纯水转移至烧杯中，将CMC-Na粉末均匀分散在烧杯中，加入搅拌子，用磁力搅拌器搅拌至完全溶解，即得0.5 % CMC-Na溶液。

译文: preparation method: Accurately weigh a certain amount of CMC-Na powder, use a measuring cylinder to measure a certain volume of pure water and transfer it to a beaker, uniformly disperse the CMC-Na powder in the beaker, add a stirring bar, and use a magnetic stirrer to stir until complete dissolution to obtain a 0.5 % CMC-Na solution.
------------------------------------------------------------------------------------
原文: 雌

译文: female
------------------------------------------------------------------------------------
原文: 中文名称

译文: Definition
------------------------------------------------------------------------------------
原文: 动物数量：8只/组，合计共16只动物；

译文: animal number: 8 per group, totaling 16 animals;
------------------------------------------------------------------------------------
原文: 达峰时间

译文: time to reach maximum
------------------------------------------------------------------------------------
原文: 留样及剩余给药制剂/供试品的处理

译文: retention samples and remaining dose formulations/test article disposal
------------------------------------------------------------------------------------
原文: 用途

译文: purpose
------------------------------------------------------------------------------------
原文: 大鼠灌胃给予sbk002后，sbk002门静脉平均血药浓度与颈静脉平均血药浓度比值为1.82；大鼠灌胃给予clo后sbk002门静脉平均血药浓度与颈静脉平均血药浓度比值为1.40。

译文: After rats were gavaged with sbk002, the mean blood concentration ratio of sbk002 in the portal vein to the mean blood concentration in the jugular vein was 1.82; after rats were gavaged with clo, the mean blood concentration ratio of sbk002 in the portal vein to the mean blood concentration in the jugular vein was 1.40.
------------------------------------------------------------------------------------
原文: 种类：SPF大小鼠维持饲料；

译文: type: SPF large mouse maintenance feed;
------------------------------------------------------------------------------------
原文: 饲料

译文: feed
------------------------------------------------------------------------------------
原文: 代谢产物sbk002门静脉/颈静脉的平均血药浓度比值：SD大鼠灌胃给予sbk002 10 mg/kg后，门静脉/颈静脉的sbk002血药浓度均值比值为1.82；SD大鼠灌胃给予30 mg/kg的clo后，门静脉/颈静脉的sbk002血药浓度均值比值为1.40，两给药组比较无明显差异。

译文: The ratio of mean blood concentration of metabolism product sbk002 in the portal vein to the jugular vein: After SD rats were gavaged with sbk002 10 mg/kg, the mean blood concentration ratio of sbk002 in the portal vein/jugular vein was 1.82; after SD rats were gavaged with 30 mg/kg of clo, the mean blood concentration ratio of sbk002 in the portal vein/jugular vein was 1.40, with no significant difference between the two dose groups.
------------------------------------------------------------------------------------
原文: 含量：98.8 %；

译文: content: 98.8 %;
------------------------------------------------------------------------------------
原文: 2.	试验材料	9

译文: 2. Study Materials 9
------------------------------------------------------------------------------------
原文: 本试验遵循的法规及技术指导原则，包括但不限于：

译文: The regulations and technical guidelines followed by this assay, including but not limited to:
------------------------------------------------------------------------------------
原文: 表1-5  SD大鼠灌胃给予sbk002及clo血浆中sbk002和SM3质谱信号

译文: Table 1-5 SD rats gavaged with sbk002 and clo plasma sbk002 and SM3 mass spectrometry signals
------------------------------------------------------------------------------------
原文: 4.6.	饲料	13

译文: 4.6. feed 13
------------------------------------------------------------------------------------
原文: 1.	基本信息	6

译文: 1. General Information 6
------------------------------------------------------------------------------------
原文: 从0 h到最后可测浓度的血药浓度-时间曲线下面积

译文: From 0 h to the last measurable concentration blood concentration-time area under curve
------------------------------------------------------------------------------------
原文: 4.9.	动物选择	15

译文: 4.9. Animal Selection 15
------------------------------------------------------------------------------------
原文: 血样处理：全血样品离心前冰盒中放置，冰盒中运输，于2 ~ 8 ℃，4000 r/min，离心10 min；分离血浆，分2管保存，EP管标签格式举例如下：

译文: Blood sample disposal: whole blood samples placed in an ice box before being centrifuged, transported in the ice box, centrifuged at 2 ~ 8 ℃, 4000 r/min for 10 min; plasma separated into 2 tubes for storage, EP tube label format example as follows:
------------------------------------------------------------------------------------
原文: 名称：

译文: name:
------------------------------------------------------------------------------------
原文: （2）本研究如用于注册申报，其档案保存期为药物上市后至少五年；本研究如不用于注册申报，其档案保存期为试验报告批准日后至少五年。

译文: (2) If this study is for registration application, its archive storage period is at least five years after the medication is marketed; if not for registration application, its archive storage period is at least five years after the assay report approval date.
------------------------------------------------------------------------------------
原文: 设备名称

译文: equipment name
------------------------------------------------------------------------------------
原文: 表1-6  SD大鼠灌胃给予sbk002及clo血浆中SM3与sbk002

译文: Table 1-6 SD rats gavaged with sbk002 and clo plasma SM3 and sbk002
------------------------------------------------------------------------------------
原文: 供试品配制方法：以配制10 mL给药制剂举例如下：

译文: Preparation of test article method: Example of preparation of 10 mL dose formulations as follows:
------------------------------------------------------------------------------------
原文: 使用LC-MS/MS法检测血浆样品中sbk002的浓度以及代谢产物的质谱信号。

译文: Using LC-MS/MS method to test the concentration of sbk002 in plasma samples and the mass spectrometry signals of metabolism products.
------------------------------------------------------------------------------------
原文: 电子邮件：xiayuye@cti-cert.com。

译文: e-mail: xiayuye@cti-cert.com.
------------------------------------------------------------------------------------
原文: 专题负责人任命书

译文: study director appointment letter
------------------------------------------------------------------------------------
原文: 等级：SPF级。

译文: grade: SPF grade.
------------------------------------------------------------------------------------
原文: 血样采集

译文: Blood sample collection
------------------------------------------------------------------------------------
原文: 批号：196766001；

译文: batch number: 196766001;
------------------------------------------------------------------------------------
原文: 结果：

译文: result:
------------------------------------------------------------------------------------
原文: 图1-3 clo剂量组2M001门静脉血浆样品典型图

译文: Figure 1-3 typical graph of 2M001 portal vein plasma sample in clo dose group
------------------------------------------------------------------------------------
原文: 种类：反渗透水（生活饮用水）；

译文: type: reverse osmosis water (domestic drinking water);
------------------------------------------------------------------------------------
原文: 型号

译文: Model
------------------------------------------------------------------------------------
原文: 测定sbk002血药浓度，定性确定活性代谢产物的有无[进行半定量研究（即活性代谢产物与sbk002的质谱信号比值）]，另计算大鼠sbk002和代谢产物门静脉/颈静脉的血药浓度比。

译文: Determination of sbk002 blood concentration, qualitative determination of the presence of active metabolism products [perform semi-quantitative studies (i.e. the mass spectrometry signal ratio of active metabolism products to sbk002)], and calculation of the blood concentration ratio of sbk002 and metabolism products between rat portal vein and jugular vein.
------------------------------------------------------------------------------------
原文: 大鼠灌胃sbk002及clo的门静脉及颈静脉代谢产物研究

译文: Study of metabolism products in the portal vein and jugular vein of rats gavaged with sbk002 and clo
------------------------------------------------------------------------------------
原文: 图1-2 sbk002剂量组1M001颈静脉血浆样品典型图

译文: Figure 1-2 typical graph of 1M001 jugular vein plasma sample in sbk002 dose group
------------------------------------------------------------------------------------
原文: 生产厂家：浙江车头制药股份有限公司；

译文: Manufacturer: Zhejiang Chemsynth Pharma Co., Ltd.;
------------------------------------------------------------------------------------
原文: 饲料、垫料、饮用水检测报告复印件；动物房温湿度报告等

译文: Copies of feed, bedding, and drinking water testing reports; animal room temperature and humidity reports, etc.
------------------------------------------------------------------------------------
原文: 门静脉H4/颈静脉H4

译文: portal vein H4/jugular vein H4
------------------------------------------------------------------------------------
原文: 从0 h 到无限时间的血药浓度-时间曲线下面积

译文: From 0 h to infinite time blood concentration-time area under curve
------------------------------------------------------------------------------------
原文: 电子邮件：779061281@qq.com。

译文: e-mail: 779061281@qq.com.
------------------------------------------------------------------------------------
原文: 江苏省昆山市高新区元丰路166号

译文: Jiangsu Province Kunshan City New & Hi-tech Industrial Development Zone Yuanfeng Road No. 166
------------------------------------------------------------------------------------
原文: 在本研究条件下，大鼠灌胃给药sbk002和clo后，均能够在门静脉（推测肠道会代谢）产生sbk002、代谢产物H4及代谢产物SM3。sbk002门静脉/颈静脉的平均血药浓度比值，代谢产物H4和SM3门静脉/颈静脉的平均质谱信号比值，两给药组之间均无明显差异。

译文: Under the conditions of this study, after rats were gavaged with doses of sbk002 and clo, sbk002, metabolism products H4 and SM3 could be produced in the portal vein (speculated to undergo intestinal metabolism). The mean blood concentration ratio of sbk002 in the portal vein/jugular vein, and the mean mass spectrometry signal ratio of metabolism products H4 and SM3 in the portal vein/jugular vein showed no significant difference between the two dose groups.
------------------------------------------------------------------------------------
原文: 因此， sbk002和clo肠道吸收或代谢趋势基本一致。

译文: Thus, the trends of intestinal absorption or metabolism of sbk002 and clo are basically the same.
------------------------------------------------------------------------------------
原文: 微升

译文: microliter
------------------------------------------------------------------------------------
原文: 试验人员组成

译文: Study Personnel composition
------------------------------------------------------------------------------------
原文: 6.	观察	16

译文: 6. observation 16
------------------------------------------------------------------------------------
原文: sbk002给药制剂配制方法：根据SD大鼠最近一次体重、给药剂量计算所需供试品的量，根据供试品的量、配制浓度计算配制体积（配制体积=供试品量×含量/配制浓度）。在室温、避光条件下，准确称取一定量的供试品至研钵中，加入适量的溶媒充分研磨后，完全转移至一定体积的容器内，用溶媒定至刻度，即得所需浓度的供试品给药制剂。

译文: sbk002 dose formulations preparation method: Based on the most recent body weight of SD rats and the dosage calculation required for the test article, calculate the amount of test article and the prepared volume according to the preparation concentration (prepared volume = amount of test article × content/preparation concentration). At room temperature, protected from excessive light, accurately weigh a certain amount of the test article into a mortar, add an appropriate amount of vehicle, fully grind, and completely transfer to a container of a certain volume, use vehicle to make up to the scale, thus obtaining the required concentration of test article dose formulations.
------------------------------------------------------------------------------------
原文: 3.3.	来源	12

译文: 3.3. source 12
------------------------------------------------------------------------------------
原文: 联系人：夏玉叶；

译文: contact person: Xia Yuye;
------------------------------------------------------------------------------------
原文: 光照：人工照明，12小时明暗交替；

译文: lighting: Artificial lighting, 12-hour light-dark cycle;
------------------------------------------------------------------------------------
原文: 《药物非临床研究质量管理规范》（原CFDA，2017年09月）；

译文: "Medication Non-clinical Study Good Laboratory Practices (GLPs)" (fCFDA, September 2017);
------------------------------------------------------------------------------------
原文: 名称/代号：sbk002；

译文: Name/Code: sbk002;
------------------------------------------------------------------------------------
原文: 剂量组

译文: dose group
------------------------------------------------------------------------------------
原文: 结论：在本研究条件下，大鼠灌胃给药sbk002和clo后，均能够在门静脉（推测肠道会代谢）产生sbk002、代谢产物H4及代谢产物SM3。且sbk002门静脉/颈静脉的平均血药浓度比值，代谢产物H4和SM3门静脉/颈静脉的平均质谱信号比值，两给药组之间均无明显差异。

译文: Conclusion: Under the conditions of this study, after rats were gavaged with doses of sbk002 and clo, sbk002, metabolism products H4 and SM3 could be produced in the portal vein (speculated to undergo intestinal metabolism). The mean blood concentration ratio of sbk002 in the portal vein/jugular vein, and the mean mass spectrometry signal ratio of metabolism products H4 and SM3 in the portal vein/jugular vein showed no significant difference between the two dose groups.
------------------------------------------------------------------------------------
原文: 供应商提供饲料的质量合格证明，合格证号：1112621900011137、1112621900011785；

译文: Supplier provided feed quality certificate, certificate numbers: 1112621900011137, 1112621900011785;
------------------------------------------------------------------------------------
原文: 合计

译文: total
------------------------------------------------------------------------------------
原文: 资料保存

译文: Storage of Relevant Data
------------------------------------------------------------------------------------
原文: 供试品管理：陈晓艳；

译文: Test article management: Chen Xiaoyan;
------------------------------------------------------------------------------------
原文: 代谢产物SM3

译文: metabolism product SM3
------------------------------------------------------------------------------------
原文: 给料方法：自由摄取（试验有特殊要求时除外）；

译文: feeding method: ad libitum (except for special assay requirements);
------------------------------------------------------------------------------------
原文: 目 录	4

译文: Table of Contents 4
------------------------------------------------------------------------------------
原文: 专题编号：B2019023-K09-01。

译文: study number: B2019023-K09-01.
------------------------------------------------------------------------------------
原文: 生产厂家：成都施贝康生物医药科技有限公司；

译文: Manufacturer: Chengdu Shibang Kang Biotechnology Co., Ltd.;
------------------------------------------------------------------------------------
原文: 试验操作：孔维晨、嵇佳佳等；

译文: assay operation: Kong Weichen, Ji Jiajia, et al.;
------------------------------------------------------------------------------------
原文: 生产许可证号：SCXK（浙）2019-0001；

译文: Production license No: SCXK (Zhejiang) 2019-0001;
------------------------------------------------------------------------------------
原文: 供水方法：饮水瓶盛装，自由摄取；

译文: water supply method: Drinking water bottles provided, ad libitum;
------------------------------------------------------------------------------------
原文: 血样采集及检测分析

译文: Blood sample collection and testing analyzed
------------------------------------------------------------------------------------
原文: 遵循的法规及技术指导原则

译文: Regulations and technical guidelines followed
------------------------------------------------------------------------------------
原文: 溶媒（0.5 % CMC-Na）溶液配制

译文: Preparation of vehicle (0.5% CMC-Na) solution
------------------------------------------------------------------------------------
原文: 总结报告及相关资料

译文: final report and related data
------------------------------------------------------------------------------------
原文: 《药物非临床药代动力学研究技术指导原则》（原CFDA，2014年05月）；

译文: "Medication Non-clinical Pharmacokinetic Study Technical Guidelines" (fCFDA, May 2014);
------------------------------------------------------------------------------------
原文: 试验方案及方案变更

译文: study protocol and protocol amendments
------------------------------------------------------------------------------------
原文: 苏州华测生物技术有限公司

译文: Suzhou Huace Biological Technology Co., Ltd.
------------------------------------------------------------------------------------
原文: 名称/代号：羧甲基纤维素钠；

译文: Name/Code: Carboxymethylcellulose Sodium;
------------------------------------------------------------------------------------
原文: 供试品

译文: test article
------------------------------------------------------------------------------------
原文: 图1-4 clo剂量组2M001颈静脉血浆样品典型图

译文: Figure 1-4 typical graph of 2M001 jugular vein plasma sample in clo dose group
------------------------------------------------------------------------------------
原文: 饮水

译文: Drinking Water
------------------------------------------------------------------------------------
原文: 表1-3  SD大鼠灌胃给予sbk002及clo后sbk002和H4质谱信号

译文: Table 1-3 SD rats gavaged with sbk002 and clo plasma sbk002 and H4 mass spectrometry signals
------------------------------------------------------------------------------------
原文: 9.2.	大鼠灌胃sbk002及clo的门静脉及颈静脉代谢产物研究	20

译文: 9.2. Study of metabolism products in the portal vein and jugular vein of rats gavaged with sbk002 and clo 20
------------------------------------------------------------------------------------
原文: 5.1.	给药信息	15

译文: 5.1. Dosing Information 15
------------------------------------------------------------------------------------
原文: 与试验有关的各种书面文件或报告

译文: Various writing documents or reports related to the assay
------------------------------------------------------------------------------------
原文: 结果分析

译文: result analyzed
------------------------------------------------------------------------------------
原文: 给药日期： 2019-09-16。

译文: dose date: 2019-09-16.
------------------------------------------------------------------------------------
原文: 供试品给药制剂在室温、密闭、遮光条件下从供试品管理部转移到动物饲养间。从供试品管理部领取的给药制剂在不使用时贮存于室温、遮光条件。

译文: Test article dose formulations transferred from the Test article management department to the Animal Housing room under room temperature, airtight, and light-protected conditions. Dose formulations received from the Test article management department should be stored under room temperature and light-protected conditions when not in use.
------------------------------------------------------------------------------------
原文: 1.4.	委托单位	6

译文: 1.4. Sponsor 6
------------------------------------------------------------------------------------
原文: 名称/代号：硫酸氢氯吡格雷/clo；

译文: Name/Code: Clopidogrel Bisulfate/clo
------------------------------------------------------------------------------------
原文: 试验目的

译文: Study Objective
------------------------------------------------------------------------------------
原文: 因此， sbk002和clo肠道吸收或代谢趋势基本一致。推测H4和SM3为活性代谢产物和进一步代谢的甲基化产物。

译文: Therefore, the trends of sbk002 and clo intestinal absorption or metabolism are basically consistent. It is speculated that H4 and SM3 are active metabolism products and further methylated metabolism products.
------------------------------------------------------------------------------------
原文: 专题名称：SD大鼠灌胃给予sbk002及硫酸氢氯吡格雷肠道吸收试验；

译文: Study Name: SDrats gavage administration of sbk002 and Clopidogrel Bisulfate intestinal absorption assay
------------------------------------------------------------------------------------
原文: 其它资料

译文: Other materials
------------------------------------------------------------------------------------
原文: 给药信息

译文: Dosing Information
------------------------------------------------------------------------------------
原文: 结果

译文: result
------------------------------------------------------------------------------------
原文: 1.1.	专题名称及编号	6

译文: 1.1. Study Name and code 6
------------------------------------------------------------------------------------
原文: 电话：028-62532315；

译文: Telephone: 028-62532315;
------------------------------------------------------------------------------------
原文: 平均值

译文: Mean
------------------------------------------------------------------------------------
原文: 门静脉

译文: portal vein
------------------------------------------------------------------------------------
原文: 研究起止日期：2019-09-11 ~ 2019-11-28

译文: Research period: 2019-09-11 ~ 2019-11-28
------------------------------------------------------------------------------------
原文: 动物标识

译文: Animal Identification
------------------------------------------------------------------------------------
原文: (4) sbk002组（10 mg/kg）灌胃3小时后门静脉和颈静脉中代谢产物H4的平均质谱响应均显著高于clo组（30 mg/kg），说明clo在肠道或肝脏转化为代谢产物H4的转化率低，与文献报道一致。

译文: (4) In the sbk002 group (10 mg/kg), 3 hours after gavage, the mean mass spectrometry responses of the metabolism product H4 in both the portal vein and the jugular vein were significantly higher than those of the clo group (30 mg/kg), indicating that the conversion rate of clo to the metabolism product H4 in the intestine or liver is low, consistent with literature reports.
------------------------------------------------------------------------------------
原文: 本试验未产生偏离试验方案的情况。本试验无试验方案的变更，试验方案见附件二。

译文: This assay did not produce any deviations from the study protocol. There were no amendments to the study protocol in this assay; see Appendix II for the study protocol.
------------------------------------------------------------------------------------
原文: 回归系数

译文: Regression Coefficient
------------------------------------------------------------------------------------
原文: 8.2.	氯吡格雷的人体代谢产物及代谢途径：	18

译文: 8.2. Metabolism products and metabolism pathways of clopidogrel in humans: 18
------------------------------------------------------------------------------------
原文: 11.	试验方案、偏离和变更	25

译文: 11. Study protocol, deviations, and amendments 25
------------------------------------------------------------------------------------
原文: 环境改善

译文: Environmental Enrichment
------------------------------------------------------------------------------------
原文: 2.4.	主要仪器设备	11

译文: 2.4. Major Instruments equipment 11
------------------------------------------------------------------------------------
原文: 参照上海药物研究所药物代谢研究中心钟大放老师发表的氯吡格雷和维卡格雷的I期单次口服给药的PK/PD临床研究（临床登记号CTR20150346），进一步研究了氯吡格雷的人体代谢产物及代谢途径[1]。

译文: Referring to the Phase I single-dose oral PK/PD clinical trials of clopidogrel and vicagrel published by Professor Zhong Dafang at the Medicinal Metabolism Research Center of the Shanghai Institute of Materia Medica (Clinical Registration No. CTR20150346), further studies were conducted on the metabolism products and metabolism pathways of clopidogrel in humans.
------------------------------------------------------------------------------------
原文: 饲养地点：苏州华测生物技术有限公司1号楼2楼屏障系统内；

译文: Laboratory animal use license No.: Within the barrier system of Building 1, Floor 2, Suzhou Huace Bioscience Co., Ltd.;
------------------------------------------------------------------------------------
原文: 实验动物选择理由：参照《药物非临床药代动力学研究技术指导原则》原CFDA，2014年05月），以及前期实验数据，SD大鼠为本实验的敏感动物。因此，本试验也选用SD大鼠为受试动物，其遗传、生物学背景（包括解剖、生理、临床病理等各种数据的正常范围）比较清。

译文: Reason for selection of laboratory animals: Refer to the "Technical Guidelines for Non-Clinical Pharmacokinetic Studies of Drugs" (CFDA, May 2014) and preliminary experimental data, SD rats were found to be the sensitive animals for this experiment. Therefore, SD rats were also selected as the test animals for this assay, as their genetic and biological backgrounds (including anatomy, physiology, and various clinical pathology data in the normal range) are relatively clear.
------------------------------------------------------------------------------------
原文: 性状：类白色粉末；

译文: Characterization: White-like powder;
------------------------------------------------------------------------------------
原文: 摘   要

译文: Summary
------------------------------------------------------------------------------------
原文: 供试品留样：按非成品制剂留样；

译文: Test article retention samples: Non-product formulation retention samples;
------------------------------------------------------------------------------------
原文: (3) 代谢产物SM3门静脉/颈静脉的平均质谱响应比值sbk002剂量组为0.85，clo组为1.12，两者比较无明显差异。

译文: (3) The mean mass spectrometry response ratio of the metabolism product SM3 in the portal vein/jugular vein for the sbk002 dose group was 0.85, while it was 1.12 for the clo group, showing no significant difference between the two.
------------------------------------------------------------------------------------
原文: 生产许可证号：SCXK(京)2019-0003；

译文: Production license No.: SCXK (Beijing) 2019-0003;
------------------------------------------------------------------------------------
原文: 基本信息

译文: General Information
------------------------------------------------------------------------------------
原文: 提供单位：成都施贝康生物医药科技有限公司。

译文: Supplier: Chengdu Shibeikang Biopharmaceutical Technology Co., Ltd.;
------------------------------------------------------------------------------------
原文: 代谢产物H4

译文: Metabolism product H4
------------------------------------------------------------------------------------
原文: 苏州华测生物技术有限公司是获得“国际实验动物评估和认可管理委员会（AAALAC International）”认证的机构，实验动物的使用获得了江苏省科学技术厅的批准。

译文: Suzhou Huace Bioscience Co., Ltd. is an institution certified by the "International Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC International)", and the use of laboratory animals has been approved by the Jiangsu Province Science and Technology Department.
------------------------------------------------------------------------------------
原文: 附件一：试验方案	27

译文: Appendix I: Study protocol 27
------------------------------------------------------------------------------------
原文: 以健康SD大鼠为受试动物，研究sbk002及硫酸氢氯吡格雷SD大鼠肠道吸收及代谢，评价其代谢靶点。

译文: Using healthy SD rats as test animals, the study investigated the intestinal absorption and metabolism of sbk002 and Clopidogrel Bisulfate in SD rats, evaluating their metabolism targets.
------------------------------------------------------------------------------------
原文: 数据采集和分析

译文: Data acquisition and analysis
------------------------------------------------------------------------------------
原文: 包括但不限于以下内容：

译文: Including but not limited to the following content:
------------------------------------------------------------------------------------
原文: 生产单位：北京科澳协力饲料有限公司；

译文: Manufacturer: Beijing Keao Xieli Feed Co., Ltd.;
------------------------------------------------------------------------------------
原文: 结果表明：

译文: The results showed that:
------------------------------------------------------------------------------------
原文: 16只

译文: 16 in total
------------------------------------------------------------------------------------
原文: 饲养笼种类：聚砜大鼠笼具，规格（L×W×H）：50 cm × 36 cm ×20 cm；

译文: Cage type: Polysulfone rat cage, size (L×W×H): 50 cm × 36 cm × 20 cm;
------------------------------------------------------------------------------------
原文: 含量：99.4 %；

译文: content: 99.4 %;
------------------------------------------------------------------------------------
原文: 2.1.	供试品	9

译文: 2.1. Test article 9
------------------------------------------------------------------------------------
原文: 供试品配制：刘露露；

译文: Preparation of test article: Liu Lulu;
------------------------------------------------------------------------------------
原文: 使用动物数量和性别：16只，雌、雄各半；

译文: Number and sex of animals used: 16 in total, half male and half female;
------------------------------------------------------------------------------------
原文: 选择健康（雌性未孕、未育）大鼠作为受试动物；

译文: Selecting healthy (female non-pregnant, nulliparous) rats as test animals;
------------------------------------------------------------------------------------
原文: 给药频率及周期：单次给药；

译文: Frequency of administration and period: Single dose;
------------------------------------------------------------------------------------
原文: 批号：190603；

译文: Batch number: 190603;
------------------------------------------------------------------------------------
原文: (3) 代谢产物H4门静脉/颈静脉的平均质谱响应比值sbk002剂量组为0.91,clo组为1.16，两者比较无明显差异。

译文: (3) The mean mass spectrometry response ratios of the metabolism product H4 in the portal vein/jugular vein for the sbk002 dose group was 0.91, and for the clo group was 1.16, showing no significant difference between the two.
------------------------------------------------------------------------------------
原文: 剩余动物的处理：本试验剩余实验动物于首次给药后一周内移交毒理运行部。

译文: Disposal of remaining animals: The remaining laboratory animals from this assay were transferred to the Toxicology Operations Department within one week after the first dose.
------------------------------------------------------------------------------------
原文: 计算门静脉和颈静脉待测物平均血药浓度和平均质谱信号。平均血药浓度比值用于评估采血位置差异和剂量组差异，比值在0.5 ~ 2之间判定为无明显差异，< 0.5或 >2判定为有明显差异；

译文: Calculation of the mean plasma concentration and mean mass spectrometry signal of the tested substance in the portal vein and jugular vein. The ratio of the mean plasma concentration is used to evaluate the differences in blood collection positions and dose groups. A ratio between 0.5 and 2 is considered to show no significant difference, while a ratio of <0.5 or >2 is considered to show a significant difference;
------------------------------------------------------------------------------------
原文: 体重和年龄

译文: Body Weight and Age
------------------------------------------------------------------------------------
原文: 1.7.	试验时间安排	8

译文: 1.7. Assay time arrangement 8
------------------------------------------------------------------------------------
原文: 留样供试品

译文: Retained test articles
------------------------------------------------------------------------------------
原文: 本试验的实施除方案特殊说明外，均遵循本机构标准操作规程（Standard Operating Procedures，SOPs）。

译文: The implementation of this assay complied with the standard operating procedures of the testing facility (Standard Operating Procedures, SOPs), unless otherwise specified in the protocol.
------------------------------------------------------------------------------------
原文: 营养成分：具有谱尼测试提供的检测报告（报告编号：GNALX2IA1S1068944），检测指标包括水分、粗蛋白、粗脂肪、粗纤维、粗灰分、钙、总磷。检测结果符合国标。

译文: Nutritional components: Testing report provided by Pony Testing (Report No.: GNALX2IA1S1068944), testing items including moisture, crude protein, crude fat, crude fiber, crude ash, calcium, and total phosphorus. The testing results meet national standards.
------------------------------------------------------------------------------------
原文: 购入时体重：雄性为314.4 ~ 335.8 g，雌性为202.2 ~ 214.8 g，分组时体重：雄性为331.9 ~ 350.8 g，雌性为214.1 ~ 224.5 g，分组时个体体重在同性别平均体重± 20 ％范围内；

译文: Body weight at purchase: Males 314.4 ~ 335.8 g, females 202.2 ~ 214.8 g, Body weight at Group Assignment: Males 331.9 ~ 350.8 g, females 214.1 ~ 224.5 g, Individual body weight at Group Assignment within ± 20% of the same sex mean body weight;
------------------------------------------------------------------------------------
原文: 动物房的环境控制和检测

译文: Environmental control in the animal room and testing
------------------------------------------------------------------------------------
原文: 规格：2 g/袋；

译文: Size: 2 g/bag;
------------------------------------------------------------------------------------
原文: 《药品注册管理办法》（原CFDA，2007年10月）；

译文: ‘Pharmaceutical Registration Administration Measures’ (CFDA, October 2007);
------------------------------------------------------------------------------------
原文: 试验材料

译文: Study Materials
------------------------------------------------------------------------------------
原文: 标准操作规程

译文: Standard Operating Procedures
------------------------------------------------------------------------------------
原文: 摄氏度

译文: Degree Celsius
------------------------------------------------------------------------------------
原文: 定量下限

译文: Lower limit of quantification
------------------------------------------------------------------------------------
原文: 动物质量合格证号：No.1909060025。

译文: Animal Qualification Certificate No: No.1909060025.
------------------------------------------------------------------------------------
原文: 方法：每组8只，雌、雄各半，共使用16只SD大鼠；组别分为sbk002剂量组、clo剂量组。sbk002剂量组单次给药剂量10 mg/kg，clo剂量组单次给药剂量30 mg/kg。给药后3小时，立即CO2麻醉，进行手术，门静脉和颈静脉各采血 0.4 mL，使用液质联用进行检测。

译文: Method: Each group of 8, half male and half female, a total of 16 SD rats; groups were divided into sbk002 dose group and clo dose group. Single dosage for sbk002 dose group was 10 mg/kg, and for clo dose group was 30 mg/kg. After dosing for 3 hours, CO2 anesthesia was performed immediately, surgery was performed to collect blood from the portal vein and jugular vein (each 0.4 mL), and testing was performed using liquid chromatography-mass spectrometry.
------------------------------------------------------------------------------------
原文: 电话：17312661834；

译文: Telephone: 17312661834;
------------------------------------------------------------------------------------
原文: 饲料批号：19083213；

译文: Feed batch number: 19083213;
------------------------------------------------------------------------------------
原文: 供试品配制

译文: Preparation of test article
------------------------------------------------------------------------------------
原文: 《生物样品定量分析方法验证指导原则》（国家药典委员会，中华人民共和国药典2015年版）；

译文: ‘Guidelines for Validation of Quantitative Analysis Methods of Biological Samples’ (Chinese Pharmacopoeia Commission, Pharmacopoeia of the People’s Republic of China 2015 Edition);
------------------------------------------------------------------------------------
原文: 保存条件：15 ℃~ 25 ℃、密闭、遮光、干燥；

译文: Storage condition: 15 ℃~ 25 ℃, airtight, protected from light, dry;
------------------------------------------------------------------------------------
原文: 选择理由：与临床用药途径一致；

译文: Reason for selection: consistent with clinical medication route;
------------------------------------------------------------------------------------
